Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-10-19Clinical Trial Update: Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W) [Phase 3]
The ACTIVE W Phase 3 trial evaluating clopidogrel with irbesartan for prevention of vascular events in atrial fibrillation has been terminat…
-
FDA approval · 2009-09-17FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's verapamil hydrochloride as an original generic application, adding a new generic calcium channel blocker to the mark…
-
CLINICAL_TRIALS research · 2009-09-03Clinical Trial Update: VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Update on a pharmacogenomics study examining how VKORC1 and CYP2C9 polymorphisms affect warfarin management across several indications, incl…
-
CLINICAL_TRIALS research · 2009-09-03Clinical Trial Update: Gene Expression Profiles in Patients With Permanent Atrial Fibrillation (AF) Versus Sinus Rhythm (SR)
This clinical trial update investigates gene expression differences between patients with permanent atrial fibrillation and those in sinus r…
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Medtronic Genetic Arrhythmia Markers for Early Detection (GAME Study)
Completed Medtronic study evaluating genetic markers for early detection of arrhythmia risk, with implications for detecting susceptibility …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: Concentrations of Amiodarone in Fat Tissue During Chronic Treatment [Phase 4]
Phase 4 trial investigating concentrations of amiodarone in fat tissue during chronic therapy in patients with arrhythmias, including atrial…
-
CLINICAL_TRIALS trial_result · 2009-07-30Clinical Trial Update: European Study of Dronedarone in Atrial Fibrillation [Phase 3]
A Phase 3 European study evaluating dronedarone for atrial fibrillation has completed.
-
FDA approval · 2009-07-20FDA Approved: DIGOXIN — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved the Amneal Pharmaceuticals of New York LLC original application for digoxin (generic digoxin). This approves a generic version …
-
CLINICAL_TRIALS trial_result · 2009-07-17Clinical Trial Update: Cardiac Surgical Treatment by Radiofrequency Ablation on Valvular Patients: Efficacy at 3 Months [NA]
The study reports 3-month efficacy results of radiofrequency ablation performed during valvular surgery in patients with atrial fibrillation…
-
FDA approval · 2009-07-10FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for amiodarone hydrochloride by Hikma Pharmaceuticals USA Inc., granting continued/updated approval …
-
FDA approval · 2009-07-09FDA Approved: FLECAINIDE ACETATE — Original Application (Chartwell RX, LLC)
FDA approved flecainide acetate under an Original Application (ANDA) for Chartwell RX, LLC, enabling a generic version of this antiarrhythmi…
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation [NA]
A completed clinical trial comparing electrical cardioversion with pharmacological cardioversion for early atrial fibrillation evaluated eff…
-
FDA approval · 2009-07-02FDA Approved: SOTALOL HYDROCHLORIDE — Original Application (ALTATHERA Pharmaceuticals, LLC)
FDA approved ALTATHERA Pharmaceuticals' original application for sotalol hydrochloride, a beta-blocker used to manage certain arrhythmias.
-
FDA approval · 2009-07-01FDA Approved: MULTAQ — Original Application (Sanofi-Aventis U.S. LLC)
FDA approved MULTAQ (dronedarone) from Sanofi-Aventis U.S. LLC as the original application. It is indicated to reduce the risk of cardiovasc…
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis [Phase 3]
Phase 3 clinical trial evaluating whether angiotensin II receptor blockers improve left ventricular reverse remodeling after aortic valve re…
-
CLINICAL_TRIALS trial_result · 2009-06-24Clinical Trial Update: Withdrawal Versus Continuation of Amiodarone in Successfully Treated Patients With Persistent Atrial Fibrillation [Phase 4]
A Phase 4 study evaluating whether stopping or continuing amiodarone is preferable in patients who have been successfully treated for persis…
-
CLINICAL_TRIALS trial_result · 2009-06-09Clinical Trial Update: Prospective Clinical Study of the Guidant Microwave Ablation System for the Treatment of PAF in the MIS Procedure [NA]
A terminated prospective study evaluated the Guidant Microwave Ablation System for treating paroxysmal atrial fibrillation during a minimall…
-
FDA approval · 2009-06-02FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2009-06-02FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc., granting additional regulator…
-
CLINICAL_TRIALS trial_result · 2009-05-29Clinical Trial Update: Irbesartan and Adhesion Molecules in AF [Phase 4]
Phase 4 clinical trial update examining the effects of irbesartan on adhesion molecules in patients with atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2009-05-29Clinical Trial Update: Line Versus Spot Ablation in Persistent Atrial Fibrillation [Phase 4]
A Phase 4 clinical trial update evaluates line-based versus spot ablation strategies for persistent atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class
This completed prospective registry update analyzes right ventricular pacing percentage in pacemaker patients and its relationship to left v…
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: The Effect of Arrhythmia Surgery on Quality of Life in Patients With Atrial Fibrillation Undergoing Cardiac Surgery [NA]
This completed clinical trial evaluated whether arrhythmia surgery improves quality of life in patients with atrial fibrillation undergoing …
-
CLINICAL_TRIALS trial_result · 2009-04-20Clinical Trial Update: GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence [Phase 3]
Phase 3 trial evaluated valsartan, an angiotensin II AT1-receptor blocker, for preventing recurrence of atrial fibrillation. The study has c…
-
CLINICAL_TRIALS trial_result · 2009-03-11Clinical Trial Update: Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers [Phase 2]
Phase 2 trial evaluating the efficacy and safety of an antiarrhythmic drug to treat atrial fibrillation in patients with pacemakers has comp…